PatternsRadar
Sign in

MEDANTAGlobal Health Limited

NSE
1,480.20INR+1.90 (+0.13%)Close · 20 Nov 2026
3 Nov 2026Last results
HealthcareSector
Healthcare ServicesIndustry
₹39,799 CrMarket cap
64.5P/E (TTM)
47.3%Delivery

Filings & corporate actions

16 results filed
CSV
Next results · Q3 FY27
Expected 4 Feb 2027 – 13 Feb 2027
Estimate: filed 35–44 days after quarter end, last 4 times
Dividend
₹0.50 per share · last 14 Aug 2026
2026
  • 3 NovresultsResults · Q2 FY27 · consolidated and standalone+5.7%NSE
  • 19 OctshareholdingShareholding · 30 Sept 2026-0.2%NSE
  • 14 AugdividendDividend · ₹0.50 per share+0.9%
  • 30 JulresultsResults · Q1 FY27 · consolidated and standalone-0.8%NSE
  • 21 JulshareholdingShareholding · 30 Jun 2026+0.8%NSE
  • 14 MayresultsResults · Q4 FY26 · consolidated and standalone+2.5%NSE
  • 13 AprshareholdingShareholding · 31 Mar 2026-0.4%NSE
  • 4 FebresultsResults · Q3 FY26 · consolidated and standalone-1.3%NSE
  • 13 JanshareholdingShareholding · 31 Dec 2025-2.1%NSE

Reaction to results · all yearsrose on day 0 in 9 of 16 CSV

QuarterFiledDay 0+5D+20DRel vol
Q2 FY273 Nov 2026+5.7%+7.8%—11.2×
Q1 FY2730 Jul 2026-0.8%+2.8%+3.9%2.4×
Q4 FY2614 May 2026+2.5%+2.2%+0.7%3.1×
Q3 FY264 Feb 2026-1.3%+2.3%-1.1%0.8×
Q2 FY267 Nov 2025-5.4%-4.0%-7.3%6.1×
Q1 FY267 Aug 2025+7.2%+1.2%+3.8%21.2×
Q4 FY2515 May 2025-3.4%-1.9%-4.6%3.6×
Q3 FY254 Feb 2025+10.7%+4.7%+20.3%5.1×
Q2 FY2514 Nov 2024+0.8%+2.8%+3.4%0.8×
Q1 FY258 Aug 2024-3.4%-5.8%-6.1%1.2×
Q4 FY2417 May 2024-1.2%-13.9%-3.4%0.2×
Q3 FY248 Feb 2024+0.8%+14.0%-0.3%1.8×
Q2 FY249 Nov 2023+5.0%+5.0%+8.5%1.8×
Q1 FY2410 Aug 2023-1.8%-0.2%+1.2%4.6×
Q4 FY2327 May 2023+0.8%+2.3%+14.1%1.6×
Q3 FY2313 Feb 2023+0.1%+11.2%+7.7%1.7×
Average+1.0%+1.9%+2.7%

Close-to-close from the session before the filing could trade. Day 0 is the first session after it.

Growth · Q2 FY27

Revenue YoY+33.6%
Profit YoY+38.3%
Interest cost YoY+65.6%
Revenue QoQ+12.7%
Profit QoQ+38.1%
CAGR2Y3Y4Y5Y6Y7Y
Revenue+20.9%+18.8%————
Profit+12.4%+14.7%————

Key data

Open1,476.00
Day range1,472.20 – 1,509.30
52-week range956.00 – 1,544.00
From 52w high-4.1%
RSI (14)68.4
ATR (14)43.24
Volume2.65L
Avg volume (20D)2.90L
Rel volume0.91×
Volatility (1Y)29.8%
Turnover₹39.6Cr
Traded value (NSE)₹39.6Cr
VWAP1,490.44
SMA 50 / 2001,370.05 / 1,267.08
Price band20%

Delivery percentage

Latest · 20 Nov 202647.3%
20-day avg54.2%
1-year avg55.3%
Percentile (own history)21st
Range11.2–95.1%
Sessions997

Over the last 20 sessions MEDANTA settled 54.2% of its traded quantity, which is above average for an NSE equity. That is in line with its own one-year average of 55.3%. The latest session ranks higher than 21% of the 997 sessions on record for it.

What delivery percentage measuresScan the whole market on delivery

Dividends, deals & holders

Dividend yield0.03%
Dividend, trailing 12M₹0.50
Paid every year for2 yr
Shareholders1.35L · -3.7% QoQ
Net bulk deals, 30D0.00%
Block deals, 30D₹0
Last bulk buy1,465 days ago

Performance returns

1D1W1M3M6M1Y
Price+0.13%+1.80%+23.54%+5.11%+19.35%+25.99%

Valuation

Market cap₹39,799 Cr
Market cap (NSE)₹39,798 Cr
Free-float cap₹26,665 Cr
P/E (TTM)64.5
P/E (NSE)64.8
EPS (TTM)22.94
P/B9.2
Net margin (TTM)12.2%
Other income / PBT12.8%
ROE15.4%
Debt / equity0.16
Shares outstanding26.87Cr
Listed16 Nov 2022

Ownership

Promoter33.00%
Promoter Δ QoQ0.00 pp
Public66.88%
FII9.91%
DII17.01%
Pledged0.00%

Quarterly results · consolidated

Q3 FY26Q4 FY26Q1 FY27Q2 FY27
Revenue (₹ Cr)1,121.01,159.01,304.11,469.0
YoY chg+18.8%+24.5%+26.5%+33.6%
Net profit (₹ Cr)95.0141.7157.3219.1
YoY chg-33.5%+39.7%-1.1%+38.3%
Net margin8.5%12.2%12.1%14.9%
EPS3.545.345.908.20

Shareholding over time

By quarter

30 Sept 2026 · promoter 33.00% · public 66.88%
11 Nov 2022: promoter 33.08%31 Dec 2022: promoter 33.08%31 Mar 2023: promoter 33.08%30 Jun 2023: promoter 33.07%30 Sept 2023: promoter 33.06%31 Dec 2023: promoter 33.05%31 Mar 2024: promoter 33.04%30 Jun 2024: promoter 33.04%30 Sept 2024: promoter 33.04%31 Dec 2024: promoter 33.03%31 Mar 2025: promoter 33.03%30 Jun 2025: promoter 33.01%30 Sept 2025: promoter 33.01%31 Dec 2025: promoter 33.01%31 Mar 2026: promoter 33.01%30 Jun 2026: promoter 33.00%30 Sept 2026: promoter 33.00%
2022-112026-09
  • Promoter
  • Public and others
Promoter
33.00%
Public
66.88%
Promoter change
0.00 pp
Filed
19 Oct 2026
FII
9.91%
DII
17.01%
Promoter pledged
0.00%

Who the public is

Mutual funds
15.97%

-0.06 pp QoQ

Insurance
0.81%

+0.15 pp QoQ

FPI
9.92%

+0.46 pp QoQ

Retail ≤ ₹2L
3.62%

-0.09 pp QoQ

HNI > ₹2L
1.78%

-0.10 pp QoQ

NRI
0.19%

+0.01 pp QoQ

Bodies corporate
7.22%

-0.03 pp QoQ

Shareholders
1,35,371

-3.7% QoQ

Major holders

As of 30 Sept 2026
HolderTypeHolding
NARESH KUMAR TREHANPromoter · Individual33.00%
DUNEARN INVESTMENTS (MAURITIUS) PTE LTDCorporate14.84%
SUNIL SACHDEVAIndividual10.04%
RJ CORP LIMITEDCorporate6.58%
INVESCO INDIA BUSINESS CYCLE FUNDMutual fund5.17%
KOTAK CONTRA FUNDMutual fund3.43%
GOVERNMENT PENSION FUND GLOBALFPI3.09%
UTI-FLEXI CAP FUNDMutual fund2.00%
POLARIS HEALTHCARE INVESTMENTS PTE LTDCorporate1.86%
CANARA ROBECO MUTUAL FUND A/C CANARA ROBECO CONSERMutual fund1.72%

Every promoter-group member, and each public holder above 1%, as filed.

Promoter and public shares of total equity, from the pattern filed each quarter. Institutional, pledge and public-breakdown figures come from the filing's XBRL, which most filings before Sep-2021 lack, so they are absent there rather than zero. Changes are against the previous filing.

Dividends

since 22 Aug 2025 CSV
Financial yearPaymentsDeclaredAdjusted
FY2026-271₹0.50₹0.50
FY2025-261₹0.50₹0.50
Ex-dateRecord dateDeclaredAdjusted
14 Aug 2026—₹0.50₹0.50
22 Aug 2025—₹0.50₹0.50

Rupees per share by ex-date, from NSE’s corporate actions; the record date is who was paid. Declared is the figure in the filing; adjusted restates it for splits and bonuses since, on the same basis as the price chart. Financial years run April to March.

52-week highs & lows

Loading…

Each session the stock traded past its previous 52-week high or low, from NSE's daily report; the previous figure is the record it broke. Prices as published, not split-adjusted.

Book closures & record dates

Loading…

NSE's corporate-action calendar: who held the stock on the record date, or through the book-closure window, was entitled to the dividend, bonus, split or rights named.

Bulk & block deals · 25 May 2026

CSV
5 of 5 deals
By year
DateDealClientQuantityPriceValue
25 May 2026Buy · blockHDFC MUTUAL FUND10.00L1,225.00₹122.5Cr
25 May 2026Sell · blockSUNIL SACHDEVA10.00L1,225.00₹122.5Cr
16 Nov 2022Buy · bulkMOTILAL OSWAL MUTUAL FUND A/C MOTILAL OSWAL LONG TERM EQUITY FUND21.00L401.00₹84.2Cr
16 Nov 2022Buy · bulkNOMURA INDIA INVESTMENT FUND MOTHER FUND A/C15.00L414.57₹62.2Cr
16 Nov 2022Buy · bulkMOTILAL OSWAL MUTUAL FUND A/C MOTILAL OSWAL LARGE AND MIDCAP FUND15.30L401.00₹61.4Cr

A bulk deal is a client trading over 0.5% of the company’s shares in a day; a block deal is one large trade in the separate block window. Quantities and prices are as NSE published them, not split-adjusted.

Every stock on this session →

Takeover-code disclosures

Loading…

Filed under SEBI’s takeover regulations when a holding crosses 5% of the company, and again with every 2% it moves after that. Shares and percentages as filed.

Every stock on this session →

Short selling, lending & margin

Loading…

Shares sold short on the day, as brokers reported them to NSE at the close. As reported, not split-adjusted.

Exchange surveillance

20 Nov 2026
  • P/E > 50 (4 quarters) · since 1 Feb 2026 — P/E above 50 on the last four quarters’ earnings.

Price band: 20% · not in the F&O ban.

From NSE’s daily surveillance, price-band and position-limit files. A stock enters the F&O ban when open interest passes 95% of its market-wide position limit and leaves it below 80%; until then no new positions can be opened. CSV: measures · band changes.

Every stock on this session →

Financials · quarterly statement

₹ crore, as filed
By year
 Q3 FY24Q4 FY24AQ1 FY25Q2 FY25Q3 FY25Q4 FY25AQ1 FY26Q2 FY26Q3 FY26Q4 FY26AQ1 FY27Q2 FY27
Revenue from operations832.6808.6861.1956.6943.4931.21,030.81,099.21,121.01,159.01,304.11,469.0
Other income21.927.421.918.216.022.920.519.721.836.722.223.6
Total income854.5836.1883.0974.8959.5954.21,051.31,118.91,142.81,195.81,326.21,492.7
Total expenses682.2693.0739.4793.7770.4770.8862.7935.1986.41,008.51,113.01,197.8
└ Finance costs17.718.218.016.016.315.013.817.121.526.726.728.1
└ Depreciation44.045.546.649.448.449.345.149.761.266.569.070.8
Profit before tax172.4143.1143.7181.1189.1133.4208.1199.8119.8187.3213.3294.8
Tax expense48.815.737.450.346.232.149.241.424.845.656.075.7
Net profit123.5127.3106.3130.8142.9101.4159.0158.495.0141.7157.3219.1
EPS4.614.743.964.875.323.775.925.893.545.365.918.21
Net margin14.84%15.75%12.34%13.68%15.14%10.89%15.42%14.41%8.48%12.22%12.06%14.92%
PBT margin20.70%17.69%16.68%18.93%20.04%14.33%20.19%18.18%10.68%16.16%16.35%20.07%
Tax rate28.33%11.00%26.03%27.76%24.44%24.03%23.62%20.73%20.66%24.36%26.26%25.67%

A audited · R restated by a later filing · negatives in parentheses. EPS and the share count are restated onto the same split-adjusted basis as the price chart, so they can be read against it; every rupee figure is exactly as filed. The balance sheet and cash flow arrive only with the half-year and annual filings, and are in their own section below. Latest filed 3 Nov 2026.

Balance sheet & cash flow · half-yearly

₹ crore, as filed
By year

Balance sheet

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Total assets4,116.04,079.54,304.14,510.14,766.25,409.55,905.06,606.2
Current assets1,579.51,362.41,508.71,400.71,533.11,728.61,674.92,088.6
└ Cash & equivalents767.2354.0424.6299.8230.2759.2127.3296.2
└ Other bank balances510.9620.4750.7683.1892.1461.01,002.91,104.6
└ Current investments0.00.00.00.00.00.00.00.0
└ Trade receivables194.2256.8215.3283.0291.9365.1411.2522.3
└ Inventories60.473.366.975.767.173.379.088.3
Total equity2,428.22,654.12,905.63,142.73,387.53,710.23,984.34,343.1
└ Attributable to owners2,428.22,654.12,905.63,141.53,386.43,707.73,961.64,323.4
└ Non-controlling interest——(0.0)1.21.12.522.719.7
└ Share capital53.653.753.753.753.753.853.753.7
Borrowings842.2440.6419.3301.9327.9526.71,190.0694.9
└ Current105.1117.0135.9109.763.872.063.036.1
└ Non-current737.1323.7283.5192.2264.1454.71,127.1658.8
Trade payables194.7229.1186.8207.1194.8250.7242.4310.2
Current liabilities572.6641.3617.7652.8618.8720.7627.1768.0
Total liabilities1,687.81,425.31,398.51,367.41,378.71,699.41,920.72,263.1
Net debt(435.9)(533.8)(755.9)(681.0)(794.5)(693.4)59.8(705.9)
Debt / equity0.350.170.140.100.100.140.300.16
Current ratio2.762.122.442.152.482.402.672.72

Cash flow, year to date

 FY23H1 FY24FY24H1 FY25FY25H1 FY26FY26H1 FY27
Operating cash flow644.5282.6612.1299.3623.8328.5714.4567.8
└ Capex(236.0)(105.7)(278.6)(264.4)(516.5)(412.7)(838.2)(339.1)
Free cash flow408.5176.9333.534.9107.2(84.2)(123.8)228.7
Investing cash flow(342.3)(225.5)(440.8)(308.9)(720.9)46.5(1,065.1)(382.9)
Financing cash flow345.6(470.4)(513.9)(115.2)(97.2)154.0247.9(16.0)
└ Dividends paid0.00.00.00.00.00.0(13.4)(9.9)
└ Buybacks0.00.00.00.00.00.00.0(14.2)
Net change in cash647.8(413.3)(342.6)(124.8)(194.4)529.0(102.9)168.9

From the half-year and annual results filings: the balance sheet from September 2022, the cash flow from September 2020. Those are when NSE’s XBRL began to carry each statement; earlier filings have it only in the attached PDF. Cash flow columns are year to date, so an H1 column covers April to September and an FY column the full year. Outflows are in parentheses. Net debt is borrowings less cash, bank balances and current investments; for banks, NBFCs and insurers it, debt to equity and the current ratio are left blank because their statements are not built that way.

Announcements & board meetings

Loading…

As the company filed them with NSE, newest first. Board meetings are dated by the meeting, which is usually a week or more after the intimation.

Every stock on this session →

MEDANTA at a glance

  • MEDANTA closed at ₹1,480.2 on 20 Nov 2026, +0.13% on the day, +26.0% over one year, 4.1% below its 52-week high of ₹1,544.
  • Delivery was 47.3% of traded quantity on 20 Nov 2026, the 21st percentile of its own 997 sessions with a reading (20-session average 54.2%, 1-year average 55.3%).
  • Market capitalisation is ₹39,799 crore at a trailing P/E of 64.5 (trailing EPS ₹22.94).
  • Q2 FY27 results (consolidated, filed 3 Nov 2026): revenue ₹1,469 crore (+33.6% year on year), net profit ₹219 crore (+38.3%); the price moved +5.7% on the first session after.
  • Promoters held 33.00% at 30 Sept 2026, unchanged on the previous filing.
  • Q3 FY27 results are expected between 4 Feb 2027 and 13 Feb 2027, going by past filing dates — an estimate, not an announcement.

About

Macro sectorHealthcare
Basic industryHospital
ISININE474Q01031
SeriesEQ
Listed16 Nov 2022
IPO price336.00 · band Rs.319 to Rs.336
IPO listing16 Nov 2022
NSE market cap · 17 Nov 2026₹38,831 Cr
Free-float market cap (NSE)₹12,766 Cr
Shares outstanding (NSE)26.89Cr
History from16 Nov 2022
Sessions997
Turnover rank#498

Sector history

  1. to 16 Aug 2026Index industry · Healthcare
  2. from 16 Aug 2026Healthcare › Healthcare › Healthcare Services › Hospital

NSE’s own classification, by the snapshot it changed on.

Prices are adjusted for splits and bonuses. Delivery figures come from NSE’s daily reports and are unavailable for older sessions. Sourced from the eod2 dataset, last updated 20 Nov 2026.